18.23USD-0.11%Mkt Cap: 368.70M $P/E: 45.571d ago
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwid…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
Indicators:|
Key Statistics
Company
Market Cap368.70M $
Enterprise Value319.20M $
Revenue (TTM)82.06M $
Gross Profit46.22M $
Net Income (TTM)-64.72M $
Revenue/Share4.070 USD
Last Price18.23 USD
Fiscal Year EndAug 2025
MR QuarterMay 2026
Employees212
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)45.57
P/E (Forward)20.66
PEG9.88
EV/EBITDA21.26
EV/Revenue3.89
P/S4.49
P/B2.65
EPS (TTM)0.40
EPS (Forward)0.88
52W Range
11.0972% of range21.01
52W High21.01 USD
52W Low11.09 USD
Profitability
Gross Margin58.38%
Oper. Margin22.84%
EBITDA Margin18.30%
Profit Margin-81.74%
ROE-51.86%
ROA-49.05%
Growth
Revenue Growth7.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF18.13M $
CapEx (TTM)3.72M $
FCF Margin22.43%
FCF Yield4.99%
Net Debt-49.50M $
Net Debt/EBITDA-3.30
Balance Sheet
Debt/Equity0.00
Current Ratio5.54
Quick Ratio5.31
Book Value/Sh6.877 USD
Cash/Share2.472 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield0.52%
Payout Ratio0.00%
Ex-Div DateJul 29, 2024
Pay DateAug 5, 2024
Splits
Last Split2:1
Split DateOct 2, 2007
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.25 USD
Upside (mean)-5.4%
Target Range16.00 USD – 18.50 USD
$16.00-5.4% to mean$18.50
# Analysts2
Ownership
Shares Out.20.22M
Float16.81M
Insiders17.19%
Institutions82.54%
Short Interest
Short Ratio2.1d
Short % Float8.58%
Short % Out.6.08%
Shares Short1.23M
Short (prev mo.)1.37M
Technical
SMA 5016.63 (+9.7%)
SMA 20016.01 (+13.8%)
Beta1.31
S&P 52W Chg20.25%
Avg Vol (30d)512.41K
Avg Vol (10d)397.94K
Technical Indicators
RSI (14)63.7
MACD0.4745
MACD Signal0.5917
MACD Hist.-0.1172
BB Upper18.42 USD
BB Middle18.25 USD
BB Lower18.09 USD
BB Width1.78%
ATR (14)0.3306 USD
Vol Ratio (20d)0.55x